Stable Gastric Pentadecapeptide BPC 157 as a Therapy and Safety Key: A Special Beneficial Pleiotropic Effect Controlling and Modulating Angiogenesis and the NO-System.

Sikiric, Predrag et al.·Pharmaceuticals (Basel·2025·
RPEP-136012025RETHINKTHC RESEARCH DATABASErethinkthc.com/research

Quick Facts

Study Type
Not classified
Evidence
Not graded
Sample
Not reported

What This Study Found

Key Numbers

How They Did This

Why This Research Matters

What This Study Doesn't Tell Us

Trust & Context

Original Title:
Stable Gastric Pentadecapeptide BPC 157 as a Therapy and Safety Key: A Special Beneficial Pleiotropic Effect Controlling and Modulating Angiogenesis and the NO-System.
Published In:
Pharmaceuticals (Basel, Switzerland), 18(6) (2025)
Database ID:
RPEP-13601

Evidence Hierarchy

Meta-Analysis / Systematic Review
Randomized Controlled Trial
Cohort / Case-Control
Cross-Sectional / ObservationalSnapshot without intervening
This study
Case Report / Animal Study
What do these levels mean? →

Read More on RethinkPeptides

Related articles coming soon.

Cite This Study

RPEP-13601·https://rethinkpeptides.com/research/RPEP-13601

APA

Sikiric, Predrag; Seiwerth, Sven; Skrtic, Anita; Staresinic, Mario; Strbe, Sanja; Vuksic, Antonia; Sikiric, Suncana; Bekic, Dinko; Soldo, Dragan; Grizelj, Boris; Novosel, Luka; Beketic Oreskovic, Lidija; Oreskovic, Ivana; Stupnisek, Mirjana; Boban Blagaic, Alenka; Dobric, Ivan. (2025). Stable Gastric Pentadecapeptide BPC 157 as a Therapy and Safety Key: A Special Beneficial Pleiotropic Effect Controlling and Modulating Angiogenesis and the NO-System.. Pharmaceuticals (Basel, Switzerland), 18(6). https://doi.org/10.3390/ph18060928

MLA

Sikiric, Predrag, et al. "Stable Gastric Pentadecapeptide BPC 157 as a Therapy and Safety Key: A Special Beneficial Pleiotropic Effect Controlling and Modulating Angiogenesis and the NO-System.." Pharmaceuticals (Basel, 2025. https://doi.org/10.3390/ph18060928

RethinkPeptides

RethinkPeptides Research Database. "Stable Gastric Pentadecapeptide BPC 157 as a Therapy and Saf..." RPEP-13601. Retrieved from https://rethinkpeptides.com/research/sikiric-2025-stable-gastric-pentadecapeptide-bpc

Access the Original Study

Study data sourced from PubMed, a service of the U.S. National Library of Medicine, National Institutes of Health.

This study breakdown was produced by the RethinkPeptides research team. We analyze and report published research findings without making health recommendations. All interpretations are based solely on the published abstract and study data.